Cytokinetics Inc. buy B. Riley
Start price
10.11.25
/
50%
€53.50
Target price
10.11.26
€77.87
Performance (%)
25.16%
Price
10:09
€66.96
Summary
This prediction is currently active. The prediction currently has a performance of 25.16%. This prediction currently runs until 10.11.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | 1.463% | 1.463% |
| iShares Core DAX® | -1.586% | 5.028% |
| iShares Nasdaq 100 | -4.148% | -0.125% |
| iShares Nikkei 225® | -6.302% | 0.528% |
| iShares S&P 500 | -3.225% | 0.470% |
Comments by B__Riley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $90.00 price target on the stock, up previously from $80.00.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by B__Riley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€44.60
04.06.24
04.06.24
€84.53
04.06.25
04.06.25
-35.43%
05.06.25
05.06.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€33.40
07.11.23
07.11.23
€61.81
07.11.24
07.11.24
61.68%
08.11.24
08.11.24